How was OCREVUS studied?

Learn more about the clinical trials behind OCREVUS.

OCREVUS for relapsing MS

OCREVUS has been proven to be effective for the treatment of relapsing MS in 2 large, identical clinical studies against REBIF.


OCREVUS is the first approved treatment for primary progressive multiple sclerosis (PPMS).

OCREVUS® (ocrelizumab) Safety

What you should know

Take a moment to understand the possible side effects of OCREVUS and who shouldn't take it.

A different approach to treating MS

OCREVUS is thought to work differently than other MS therapies.